Literature DB >> 13171909

[Tuberculoid leprosy; a case report with special reference to its neurohistological changes and the therapeutic use of thiosemicarbazones].

H G CREUTZFELDT, H E KLEINE-NATROP.   

Abstract

Entities:  

Keywords:  LEPROSY; THIOSEMICARBAZONES/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13171909     DOI： 10.1007/BF00347859

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr


× No keyword cloud information.
  6 in total

1.  [Modern classification of leprosy].

Authors:  J GAY PRIETO
Journal:  Hautarzt       Date:  1952-06       Impact factor: 0.751

2.  [The leprosy of the middle-aged Germany. Religious, medical & legal aspects; its traces in Regensburg].

Authors:  W SCHONFELD
Journal:  Dermatol Wochenschr       Date:  1952

3.  [Results of the treatment of leprosy with thiosemicarbazones].

Authors:  J GOMEZ ORGANEJA; M SUCH; A GARCIA PEREZ
Journal:  Actas Dermosifiliogr       Date:  1951-03

4.  Thiosemicarbazone (TB-1) in the treatment of preliminary communication.

Authors:  M VEGAS; J CONVIT; J A MEDINA; E de BLOMENFIELD
Journal:  Int J Lepr       Date:  1950 Oct-Dec

5.  Current status of therapy in leprosy.

Authors:  F A JOHANSEN; P T ERICKSON
Journal:  J Am Med Assoc       Date:  1950-11-18

6.  Thiosemicarbazone in the treatment of leprosy.

Authors:  G A RYRIE
Journal:  Lancet       Date:  1950-08-19       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.